Global Swine Mycoplasma Pneumonia Live Vaccine Supply, Demand and Key Producers, 2023-2029
The global Swine Mycoplasma Pneumonia Live Vaccine market size is expected to reach $ 329.6 million by 2029, rising at a market growth of 5.9% CAGR during the forecast period (2023-2029).
Swine Mycoplasma Pneumonia Live Vaccine is a vaccine used to prevent respiratory diseases caused by Mycoplasma hyopneumoniae in pigs. This vaccine is a live attenuated vaccine that helps to stimulate the pig's immune system to recognize and fight against the bacteria that causes pneumonia.
This report studies the global Swine Mycoplasma Pneumonia Live Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Swine Mycoplasma Pneumonia Live Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Swine Mycoplasma Pneumonia Live Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Swine Mycoplasma Pneumonia Live Vaccine total production and demand, 2018-2029, (K Units)
Global Swine Mycoplasma Pneumonia Live Vaccine total production value, 2018-2029, (USD Million)
Global Swine Mycoplasma Pneumonia Live Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Swine Mycoplasma Pneumonia Live Vaccine consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Swine Mycoplasma Pneumonia Live Vaccine domestic production, consumption, key domestic manufacturers and share
Global Swine Mycoplasma Pneumonia Live Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Swine Mycoplasma Pneumonia Live Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Swine Mycoplasma Pneumonia Live Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Swine Mycoplasma Pneumonia Live Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Zoetis, Boehringer Ingelheim, Merck, HIPRA, Ceva Sant? Animale, Harbin Pharmaceutical Group, Qilu Animal Health Products, Guangdong Winsun Bio-Pharmaceutical and Jilin HeYuan Bioengineering, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Swine Mycoplasma Pneumonia Live Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Swine Mycoplasma Pneumonia Live Vaccine Market, By Region:
1. How big is the global Swine Mycoplasma Pneumonia Live Vaccine market?
2. What is the demand of the global Swine Mycoplasma Pneumonia Live Vaccine market?
3. What is the year over year growth of the global Swine Mycoplasma Pneumonia Live Vaccine market?
4. What is the production and production value of the global Swine Mycoplasma Pneumonia Live Vaccine market?
5. Who are the key producers in the global Swine Mycoplasma Pneumonia Live Vaccine market?
6. What are the growth factors driving the market demand?
Swine Mycoplasma Pneumonia Live Vaccine is a vaccine used to prevent respiratory diseases caused by Mycoplasma hyopneumoniae in pigs. This vaccine is a live attenuated vaccine that helps to stimulate the pig's immune system to recognize and fight against the bacteria that causes pneumonia.
This report studies the global Swine Mycoplasma Pneumonia Live Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Swine Mycoplasma Pneumonia Live Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Swine Mycoplasma Pneumonia Live Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Swine Mycoplasma Pneumonia Live Vaccine total production and demand, 2018-2029, (K Units)
Global Swine Mycoplasma Pneumonia Live Vaccine total production value, 2018-2029, (USD Million)
Global Swine Mycoplasma Pneumonia Live Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Swine Mycoplasma Pneumonia Live Vaccine consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Swine Mycoplasma Pneumonia Live Vaccine domestic production, consumption, key domestic manufacturers and share
Global Swine Mycoplasma Pneumonia Live Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Swine Mycoplasma Pneumonia Live Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Swine Mycoplasma Pneumonia Live Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Swine Mycoplasma Pneumonia Live Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Zoetis, Boehringer Ingelheim, Merck, HIPRA, Ceva Sant? Animale, Harbin Pharmaceutical Group, Qilu Animal Health Products, Guangdong Winsun Bio-Pharmaceutical and Jilin HeYuan Bioengineering, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Swine Mycoplasma Pneumonia Live Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Swine Mycoplasma Pneumonia Live Vaccine Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- 168 Strains
- RM48 Strains
- Other
- Piglets
- Adult Pigs
- Zoetis
- Boehringer Ingelheim
- Merck
- HIPRA
- Ceva Sant? Animale
- Harbin Pharmaceutical Group
- Qilu Animal Health Products
- Guangdong Winsun Bio-Pharmaceutical
- Jilin HeYuan Bioengineering
- Jofunhwa Biotechnology
1. How big is the global Swine Mycoplasma Pneumonia Live Vaccine market?
2. What is the demand of the global Swine Mycoplasma Pneumonia Live Vaccine market?
3. What is the year over year growth of the global Swine Mycoplasma Pneumonia Live Vaccine market?
4. What is the production and production value of the global Swine Mycoplasma Pneumonia Live Vaccine market?
5. Who are the key producers in the global Swine Mycoplasma Pneumonia Live Vaccine market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Swine Mycoplasma Pneumonia Live Vaccine Introduction
1.2 World Swine Mycoplasma Pneumonia Live Vaccine Supply & Forecast
1.2.1 World Swine Mycoplasma Pneumonia Live Vaccine Production Value (2018 & 2022 & 2029)
1.2.2 World Swine Mycoplasma Pneumonia Live Vaccine Production (2018-2029)
1.2.3 World Swine Mycoplasma Pneumonia Live Vaccine Pricing Trends (2018-2029)
1.3 World Swine Mycoplasma Pneumonia Live Vaccine Production by Region (Based on Production Site)
1.3.1 World Swine Mycoplasma Pneumonia Live Vaccine Production Value by Region (2018-2029)
1.3.2 World Swine Mycoplasma Pneumonia Live Vaccine Production by Region (2018-2029)
1.3.3 World Swine Mycoplasma Pneumonia Live Vaccine Average Price by Region (2018-2029)
1.3.4 North America Swine Mycoplasma Pneumonia Live Vaccine Production (2018-2029)
1.3.5 Europe Swine Mycoplasma Pneumonia Live Vaccine Production (2018-2029)
1.3.6 China Swine Mycoplasma Pneumonia Live Vaccine Production (2018-2029)
1.3.7 Japan Swine Mycoplasma Pneumonia Live Vaccine Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Swine Mycoplasma Pneumonia Live Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Swine Mycoplasma Pneumonia Live Vaccine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Swine Mycoplasma Pneumonia Live Vaccine Demand (2018-2029)
2.2 World Swine Mycoplasma Pneumonia Live Vaccine Consumption by Region
2.2.1 World Swine Mycoplasma Pneumonia Live Vaccine Consumption by Region (2018-2023)
2.2.2 World Swine Mycoplasma Pneumonia Live Vaccine Consumption Forecast by Region (2024-2029)
2.3 United States Swine Mycoplasma Pneumonia Live Vaccine Consumption (2018-2029)
2.4 China Swine Mycoplasma Pneumonia Live Vaccine Consumption (2018-2029)
2.5 Europe Swine Mycoplasma Pneumonia Live Vaccine Consumption (2018-2029)
2.6 Japan Swine Mycoplasma Pneumonia Live Vaccine Consumption (2018-2029)
2.7 South Korea Swine Mycoplasma Pneumonia Live Vaccine Consumption (2018-2029)
2.8 ASEAN Swine Mycoplasma Pneumonia Live Vaccine Consumption (2018-2029)
2.9 India Swine Mycoplasma Pneumonia Live Vaccine Consumption (2018-2029)
3 WORLD SWINE MYCOPLASMA PNEUMONIA LIVE VACCINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Swine Mycoplasma Pneumonia Live Vaccine Production Value by Manufacturer (2018-2023)
3.2 World Swine Mycoplasma Pneumonia Live Vaccine Production by Manufacturer (2018-2023)
3.3 World Swine Mycoplasma Pneumonia Live Vaccine Average Price by Manufacturer (2018-2023)
3.4 Swine Mycoplasma Pneumonia Live Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Swine Mycoplasma Pneumonia Live Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Swine Mycoplasma Pneumonia Live Vaccine in 2022
3.5.3 Global Concentration Ratios (CR8) for Swine Mycoplasma Pneumonia Live Vaccine in 2022
3.6 Swine Mycoplasma Pneumonia Live Vaccine Market: Overall Company Footprint Analysis
3.6.1 Swine Mycoplasma Pneumonia Live Vaccine Market: Region Footprint
3.6.2 Swine Mycoplasma Pneumonia Live Vaccine Market: Company Product Type Footprint
3.6.3 Swine Mycoplasma Pneumonia Live Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Swine Mycoplasma Pneumonia Live Vaccine Production Value Comparison
4.1.1 United States VS China: Swine Mycoplasma Pneumonia Live Vaccine Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Swine Mycoplasma Pneumonia Live Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Swine Mycoplasma Pneumonia Live Vaccine Production Comparison
4.2.1 United States VS China: Swine Mycoplasma Pneumonia Live Vaccine Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Swine Mycoplasma Pneumonia Live Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Swine Mycoplasma Pneumonia Live Vaccine Consumption Comparison
4.3.1 United States VS China: Swine Mycoplasma Pneumonia Live Vaccine Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Swine Mycoplasma Pneumonia Live Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Swine Mycoplasma Pneumonia Live Vaccine Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Swine Mycoplasma Pneumonia Live Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Swine Mycoplasma Pneumonia Live Vaccine Production Value (2018-2023)
4.4.3 United States Based Manufacturers Swine Mycoplasma Pneumonia Live Vaccine Production (2018-2023)
4.5 China Based Swine Mycoplasma Pneumonia Live Vaccine Manufacturers and Market Share
4.5.1 China Based Swine Mycoplasma Pneumonia Live Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Swine Mycoplasma Pneumonia Live Vaccine Production Value (2018-2023)
4.5.3 China Based Manufacturers Swine Mycoplasma Pneumonia Live Vaccine Production (2018-2023)
4.6 Rest of World Based Swine Mycoplasma Pneumonia Live Vaccine Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Swine Mycoplasma Pneumonia Live Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Swine Mycoplasma Pneumonia Live Vaccine Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Swine Mycoplasma Pneumonia Live Vaccine Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Swine Mycoplasma Pneumonia Live Vaccine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 168 Strains
5.2.2 RM48 Strains
5.2.3 Other
5.3 Market Segment by Type
5.3.1 World Swine Mycoplasma Pneumonia Live Vaccine Production by Type (2018-2029)
5.3.2 World Swine Mycoplasma Pneumonia Live Vaccine Production Value by Type (2018-2029)
5.3.3 World Swine Mycoplasma Pneumonia Live Vaccine Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Swine Mycoplasma Pneumonia Live Vaccine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Piglets
6.2.2 Adult Pigs
6.3 Market Segment by Application
6.3.1 World Swine Mycoplasma Pneumonia Live Vaccine Production by Application (2018-2029)
6.3.2 World Swine Mycoplasma Pneumonia Live Vaccine Production Value by Application (2018-2029)
6.3.3 World Swine Mycoplasma Pneumonia Live Vaccine Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Zoetis
7.1.1 Zoetis Details
7.1.2 Zoetis Major Business
7.1.3 Zoetis Swine Mycoplasma Pneumonia Live Vaccine Product and Services
7.1.4 Zoetis Swine Mycoplasma Pneumonia Live Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Zoetis Recent Developments/Updates
7.1.6 Zoetis Competitive Strengths & Weaknesses
7.2 Boehringer Ingelheim
7.2.1 Boehringer Ingelheim Details
7.2.2 Boehringer Ingelheim Major Business
7.2.3 Boehringer Ingelheim Swine Mycoplasma Pneumonia Live Vaccine Product and Services
7.2.4 Boehringer Ingelheim Swine Mycoplasma Pneumonia Live Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Boehringer Ingelheim Recent Developments/Updates
7.2.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.3 Merck
7.3.1 Merck Details
7.3.2 Merck Major Business
7.3.3 Merck Swine Mycoplasma Pneumonia Live Vaccine Product and Services
7.3.4 Merck Swine Mycoplasma Pneumonia Live Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Merck Recent Developments/Updates
7.3.6 Merck Competitive Strengths & Weaknesses
7.4 HIPRA
7.4.1 HIPRA Details
7.4.2 HIPRA Major Business
7.4.3 HIPRA Swine Mycoplasma Pneumonia Live Vaccine Product and Services
7.4.4 HIPRA Swine Mycoplasma Pneumonia Live Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 HIPRA Recent Developments/Updates
7.4.6 HIPRA Competitive Strengths & Weaknesses
7.5 Ceva Sant? Animale
7.5.1 Ceva Sant? Animale Details
7.5.2 Ceva Sant? Animale Major Business
7.5.3 Ceva Sant? Animale Swine Mycoplasma Pneumonia Live Vaccine Product and Services
7.5.4 Ceva Sant? Animale Swine Mycoplasma Pneumonia Live Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Ceva Sant? Animale Recent Developments/Updates
7.5.6 Ceva Sant? Animale Competitive Strengths & Weaknesses
7.6 Harbin Pharmaceutical Group
7.6.1 Harbin Pharmaceutical Group Details
7.6.2 Harbin Pharmaceutical Group Major Business
7.6.3 Harbin Pharmaceutical Group Swine Mycoplasma Pneumonia Live Vaccine Product and Services
7.6.4 Harbin Pharmaceutical Group Swine Mycoplasma Pneumonia Live Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Harbin Pharmaceutical Group Recent Developments/Updates
7.6.6 Harbin Pharmaceutical Group Competitive Strengths & Weaknesses
7.7 Qilu Animal Health Products
7.7.1 Qilu Animal Health Products Details
7.7.2 Qilu Animal Health Products Major Business
7.7.3 Qilu Animal Health Products Swine Mycoplasma Pneumonia Live Vaccine Product and Services
7.7.4 Qilu Animal Health Products Swine Mycoplasma Pneumonia Live Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Qilu Animal Health Products Recent Developments/Updates
7.7.6 Qilu Animal Health Products Competitive Strengths & Weaknesses
7.8 Guangdong Winsun Bio-Pharmaceutical
7.8.1 Guangdong Winsun Bio-Pharmaceutical Details
7.8.2 Guangdong Winsun Bio-Pharmaceutical Major Business
7.8.3 Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Pneumonia Live Vaccine Product and Services
7.8.4 Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Pneumonia Live Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Guangdong Winsun Bio-Pharmaceutical Recent Developments/Updates
7.8.6 Guangdong Winsun Bio-Pharmaceutical Competitive Strengths & Weaknesses
7.9 Jilin HeYuan Bioengineering
7.9.1 Jilin HeYuan Bioengineering Details
7.9.2 Jilin HeYuan Bioengineering Major Business
7.9.3 Jilin HeYuan Bioengineering Swine Mycoplasma Pneumonia Live Vaccine Product and Services
7.9.4 Jilin HeYuan Bioengineering Swine Mycoplasma Pneumonia Live Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Jilin HeYuan Bioengineering Recent Developments/Updates
7.9.6 Jilin HeYuan Bioengineering Competitive Strengths & Weaknesses
7.10 Jofunhwa Biotechnology
7.10.1 Jofunhwa Biotechnology Details
7.10.2 Jofunhwa Biotechnology Major Business
7.10.3 Jofunhwa Biotechnology Swine Mycoplasma Pneumonia Live Vaccine Product and Services
7.10.4 Jofunhwa Biotechnology Swine Mycoplasma Pneumonia Live Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Jofunhwa Biotechnology Recent Developments/Updates
7.10.6 Jofunhwa Biotechnology Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Swine Mycoplasma Pneumonia Live Vaccine Industry Chain
8.2 Swine Mycoplasma Pneumonia Live Vaccine Upstream Analysis
8.2.1 Swine Mycoplasma Pneumonia Live Vaccine Core Raw Materials
8.2.2 Main Manufacturers of Swine Mycoplasma Pneumonia Live Vaccine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Swine Mycoplasma Pneumonia Live Vaccine Production Mode
8.6 Swine Mycoplasma Pneumonia Live Vaccine Procurement Model
8.7 Swine Mycoplasma Pneumonia Live Vaccine Industry Sales Model and Sales Channels
8.7.1 Swine Mycoplasma Pneumonia Live Vaccine Sales Model
8.7.2 Swine Mycoplasma Pneumonia Live Vaccine Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Swine Mycoplasma Pneumonia Live Vaccine Introduction
1.2 World Swine Mycoplasma Pneumonia Live Vaccine Supply & Forecast
1.2.1 World Swine Mycoplasma Pneumonia Live Vaccine Production Value (2018 & 2022 & 2029)
1.2.2 World Swine Mycoplasma Pneumonia Live Vaccine Production (2018-2029)
1.2.3 World Swine Mycoplasma Pneumonia Live Vaccine Pricing Trends (2018-2029)
1.3 World Swine Mycoplasma Pneumonia Live Vaccine Production by Region (Based on Production Site)
1.3.1 World Swine Mycoplasma Pneumonia Live Vaccine Production Value by Region (2018-2029)
1.3.2 World Swine Mycoplasma Pneumonia Live Vaccine Production by Region (2018-2029)
1.3.3 World Swine Mycoplasma Pneumonia Live Vaccine Average Price by Region (2018-2029)
1.3.4 North America Swine Mycoplasma Pneumonia Live Vaccine Production (2018-2029)
1.3.5 Europe Swine Mycoplasma Pneumonia Live Vaccine Production (2018-2029)
1.3.6 China Swine Mycoplasma Pneumonia Live Vaccine Production (2018-2029)
1.3.7 Japan Swine Mycoplasma Pneumonia Live Vaccine Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Swine Mycoplasma Pneumonia Live Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Swine Mycoplasma Pneumonia Live Vaccine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Swine Mycoplasma Pneumonia Live Vaccine Demand (2018-2029)
2.2 World Swine Mycoplasma Pneumonia Live Vaccine Consumption by Region
2.2.1 World Swine Mycoplasma Pneumonia Live Vaccine Consumption by Region (2018-2023)
2.2.2 World Swine Mycoplasma Pneumonia Live Vaccine Consumption Forecast by Region (2024-2029)
2.3 United States Swine Mycoplasma Pneumonia Live Vaccine Consumption (2018-2029)
2.4 China Swine Mycoplasma Pneumonia Live Vaccine Consumption (2018-2029)
2.5 Europe Swine Mycoplasma Pneumonia Live Vaccine Consumption (2018-2029)
2.6 Japan Swine Mycoplasma Pneumonia Live Vaccine Consumption (2018-2029)
2.7 South Korea Swine Mycoplasma Pneumonia Live Vaccine Consumption (2018-2029)
2.8 ASEAN Swine Mycoplasma Pneumonia Live Vaccine Consumption (2018-2029)
2.9 India Swine Mycoplasma Pneumonia Live Vaccine Consumption (2018-2029)
3 WORLD SWINE MYCOPLASMA PNEUMONIA LIVE VACCINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Swine Mycoplasma Pneumonia Live Vaccine Production Value by Manufacturer (2018-2023)
3.2 World Swine Mycoplasma Pneumonia Live Vaccine Production by Manufacturer (2018-2023)
3.3 World Swine Mycoplasma Pneumonia Live Vaccine Average Price by Manufacturer (2018-2023)
3.4 Swine Mycoplasma Pneumonia Live Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Swine Mycoplasma Pneumonia Live Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Swine Mycoplasma Pneumonia Live Vaccine in 2022
3.5.3 Global Concentration Ratios (CR8) for Swine Mycoplasma Pneumonia Live Vaccine in 2022
3.6 Swine Mycoplasma Pneumonia Live Vaccine Market: Overall Company Footprint Analysis
3.6.1 Swine Mycoplasma Pneumonia Live Vaccine Market: Region Footprint
3.6.2 Swine Mycoplasma Pneumonia Live Vaccine Market: Company Product Type Footprint
3.6.3 Swine Mycoplasma Pneumonia Live Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Swine Mycoplasma Pneumonia Live Vaccine Production Value Comparison
4.1.1 United States VS China: Swine Mycoplasma Pneumonia Live Vaccine Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Swine Mycoplasma Pneumonia Live Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Swine Mycoplasma Pneumonia Live Vaccine Production Comparison
4.2.1 United States VS China: Swine Mycoplasma Pneumonia Live Vaccine Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Swine Mycoplasma Pneumonia Live Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Swine Mycoplasma Pneumonia Live Vaccine Consumption Comparison
4.3.1 United States VS China: Swine Mycoplasma Pneumonia Live Vaccine Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Swine Mycoplasma Pneumonia Live Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Swine Mycoplasma Pneumonia Live Vaccine Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Swine Mycoplasma Pneumonia Live Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Swine Mycoplasma Pneumonia Live Vaccine Production Value (2018-2023)
4.4.3 United States Based Manufacturers Swine Mycoplasma Pneumonia Live Vaccine Production (2018-2023)
4.5 China Based Swine Mycoplasma Pneumonia Live Vaccine Manufacturers and Market Share
4.5.1 China Based Swine Mycoplasma Pneumonia Live Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Swine Mycoplasma Pneumonia Live Vaccine Production Value (2018-2023)
4.5.3 China Based Manufacturers Swine Mycoplasma Pneumonia Live Vaccine Production (2018-2023)
4.6 Rest of World Based Swine Mycoplasma Pneumonia Live Vaccine Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Swine Mycoplasma Pneumonia Live Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Swine Mycoplasma Pneumonia Live Vaccine Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Swine Mycoplasma Pneumonia Live Vaccine Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Swine Mycoplasma Pneumonia Live Vaccine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 168 Strains
5.2.2 RM48 Strains
5.2.3 Other
5.3 Market Segment by Type
5.3.1 World Swine Mycoplasma Pneumonia Live Vaccine Production by Type (2018-2029)
5.3.2 World Swine Mycoplasma Pneumonia Live Vaccine Production Value by Type (2018-2029)
5.3.3 World Swine Mycoplasma Pneumonia Live Vaccine Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Swine Mycoplasma Pneumonia Live Vaccine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Piglets
6.2.2 Adult Pigs
6.3 Market Segment by Application
6.3.1 World Swine Mycoplasma Pneumonia Live Vaccine Production by Application (2018-2029)
6.3.2 World Swine Mycoplasma Pneumonia Live Vaccine Production Value by Application (2018-2029)
6.3.3 World Swine Mycoplasma Pneumonia Live Vaccine Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Zoetis
7.1.1 Zoetis Details
7.1.2 Zoetis Major Business
7.1.3 Zoetis Swine Mycoplasma Pneumonia Live Vaccine Product and Services
7.1.4 Zoetis Swine Mycoplasma Pneumonia Live Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Zoetis Recent Developments/Updates
7.1.6 Zoetis Competitive Strengths & Weaknesses
7.2 Boehringer Ingelheim
7.2.1 Boehringer Ingelheim Details
7.2.2 Boehringer Ingelheim Major Business
7.2.3 Boehringer Ingelheim Swine Mycoplasma Pneumonia Live Vaccine Product and Services
7.2.4 Boehringer Ingelheim Swine Mycoplasma Pneumonia Live Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Boehringer Ingelheim Recent Developments/Updates
7.2.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.3 Merck
7.3.1 Merck Details
7.3.2 Merck Major Business
7.3.3 Merck Swine Mycoplasma Pneumonia Live Vaccine Product and Services
7.3.4 Merck Swine Mycoplasma Pneumonia Live Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Merck Recent Developments/Updates
7.3.6 Merck Competitive Strengths & Weaknesses
7.4 HIPRA
7.4.1 HIPRA Details
7.4.2 HIPRA Major Business
7.4.3 HIPRA Swine Mycoplasma Pneumonia Live Vaccine Product and Services
7.4.4 HIPRA Swine Mycoplasma Pneumonia Live Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 HIPRA Recent Developments/Updates
7.4.6 HIPRA Competitive Strengths & Weaknesses
7.5 Ceva Sant? Animale
7.5.1 Ceva Sant? Animale Details
7.5.2 Ceva Sant? Animale Major Business
7.5.3 Ceva Sant? Animale Swine Mycoplasma Pneumonia Live Vaccine Product and Services
7.5.4 Ceva Sant? Animale Swine Mycoplasma Pneumonia Live Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Ceva Sant? Animale Recent Developments/Updates
7.5.6 Ceva Sant? Animale Competitive Strengths & Weaknesses
7.6 Harbin Pharmaceutical Group
7.6.1 Harbin Pharmaceutical Group Details
7.6.2 Harbin Pharmaceutical Group Major Business
7.6.3 Harbin Pharmaceutical Group Swine Mycoplasma Pneumonia Live Vaccine Product and Services
7.6.4 Harbin Pharmaceutical Group Swine Mycoplasma Pneumonia Live Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Harbin Pharmaceutical Group Recent Developments/Updates
7.6.6 Harbin Pharmaceutical Group Competitive Strengths & Weaknesses
7.7 Qilu Animal Health Products
7.7.1 Qilu Animal Health Products Details
7.7.2 Qilu Animal Health Products Major Business
7.7.3 Qilu Animal Health Products Swine Mycoplasma Pneumonia Live Vaccine Product and Services
7.7.4 Qilu Animal Health Products Swine Mycoplasma Pneumonia Live Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Qilu Animal Health Products Recent Developments/Updates
7.7.6 Qilu Animal Health Products Competitive Strengths & Weaknesses
7.8 Guangdong Winsun Bio-Pharmaceutical
7.8.1 Guangdong Winsun Bio-Pharmaceutical Details
7.8.2 Guangdong Winsun Bio-Pharmaceutical Major Business
7.8.3 Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Pneumonia Live Vaccine Product and Services
7.8.4 Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Pneumonia Live Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Guangdong Winsun Bio-Pharmaceutical Recent Developments/Updates
7.8.6 Guangdong Winsun Bio-Pharmaceutical Competitive Strengths & Weaknesses
7.9 Jilin HeYuan Bioengineering
7.9.1 Jilin HeYuan Bioengineering Details
7.9.2 Jilin HeYuan Bioengineering Major Business
7.9.3 Jilin HeYuan Bioengineering Swine Mycoplasma Pneumonia Live Vaccine Product and Services
7.9.4 Jilin HeYuan Bioengineering Swine Mycoplasma Pneumonia Live Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Jilin HeYuan Bioengineering Recent Developments/Updates
7.9.6 Jilin HeYuan Bioengineering Competitive Strengths & Weaknesses
7.10 Jofunhwa Biotechnology
7.10.1 Jofunhwa Biotechnology Details
7.10.2 Jofunhwa Biotechnology Major Business
7.10.3 Jofunhwa Biotechnology Swine Mycoplasma Pneumonia Live Vaccine Product and Services
7.10.4 Jofunhwa Biotechnology Swine Mycoplasma Pneumonia Live Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Jofunhwa Biotechnology Recent Developments/Updates
7.10.6 Jofunhwa Biotechnology Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Swine Mycoplasma Pneumonia Live Vaccine Industry Chain
8.2 Swine Mycoplasma Pneumonia Live Vaccine Upstream Analysis
8.2.1 Swine Mycoplasma Pneumonia Live Vaccine Core Raw Materials
8.2.2 Main Manufacturers of Swine Mycoplasma Pneumonia Live Vaccine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Swine Mycoplasma Pneumonia Live Vaccine Production Mode
8.6 Swine Mycoplasma Pneumonia Live Vaccine Procurement Model
8.7 Swine Mycoplasma Pneumonia Live Vaccine Industry Sales Model and Sales Channels
8.7.1 Swine Mycoplasma Pneumonia Live Vaccine Sales Model
8.7.2 Swine Mycoplasma Pneumonia Live Vaccine Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Swine Mycoplasma Pneumonia Live Vaccine Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Swine Mycoplasma Pneumonia Live Vaccine Production Value by Region (2018-2023) & (USD Million)
Table 3. World Swine Mycoplasma Pneumonia Live Vaccine Production Value by Region (2024-2029) & (USD Million)
Table 4. World Swine Mycoplasma Pneumonia Live Vaccine Production Value Market Share by Region (2018-2023)
Table 5. World Swine Mycoplasma Pneumonia Live Vaccine Production Value Market Share by Region (2024-2029)
Table 6. World Swine Mycoplasma Pneumonia Live Vaccine Production by Region (2018-2023) & (K Units)
Table 7. World Swine Mycoplasma Pneumonia Live Vaccine Production by Region (2024-2029) & (K Units)
Table 8. World Swine Mycoplasma Pneumonia Live Vaccine Production Market Share by Region (2018-2023)
Table 9. World Swine Mycoplasma Pneumonia Live Vaccine Production Market Share by Region (2024-2029)
Table 10. World Swine Mycoplasma Pneumonia Live Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Swine Mycoplasma Pneumonia Live Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Swine Mycoplasma Pneumonia Live Vaccine Major Market Trends
Table 13. World Swine Mycoplasma Pneumonia Live Vaccine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Swine Mycoplasma Pneumonia Live Vaccine Consumption by Region (2018-2023) & (K Units)
Table 15. World Swine Mycoplasma Pneumonia Live Vaccine Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Swine Mycoplasma Pneumonia Live Vaccine Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Swine Mycoplasma Pneumonia Live Vaccine Producers in 2022
Table 18. World Swine Mycoplasma Pneumonia Live Vaccine Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Swine Mycoplasma Pneumonia Live Vaccine Producers in 2022
Table 20. World Swine Mycoplasma Pneumonia Live Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Swine Mycoplasma Pneumonia Live Vaccine Company Evaluation Quadrant
Table 22. World Swine Mycoplasma Pneumonia Live Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Swine Mycoplasma Pneumonia Live Vaccine Production Site of Key Manufacturer
Table 24. Swine Mycoplasma Pneumonia Live Vaccine Market: Company Product Type Footprint
Table 25. Swine Mycoplasma Pneumonia Live Vaccine Market: Company Product Application Footprint
Table 26. Swine Mycoplasma Pneumonia Live Vaccine Competitive Factors
Table 27. Swine Mycoplasma Pneumonia Live Vaccine New Entrant and Capacity Expansion Plans
Table 28. Swine Mycoplasma Pneumonia Live Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Swine Mycoplasma Pneumonia Live Vaccine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Swine Mycoplasma Pneumonia Live Vaccine Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Swine Mycoplasma Pneumonia Live Vaccine Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Swine Mycoplasma Pneumonia Live Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Swine Mycoplasma Pneumonia Live Vaccine Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Swine Mycoplasma Pneumonia Live Vaccine Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Swine Mycoplasma Pneumonia Live Vaccine Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Swine Mycoplasma Pneumonia Live Vaccine Production Market Share (2018-2023)
Table 37. China Based Swine Mycoplasma Pneumonia Live Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Swine Mycoplasma Pneumonia Live Vaccine Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Swine Mycoplasma Pneumonia Live Vaccine Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Swine Mycoplasma Pneumonia Live Vaccine Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Swine Mycoplasma Pneumonia Live Vaccine Production Market Share (2018-2023)
Table 42. Rest of World Based Swine Mycoplasma Pneumonia Live Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Swine Mycoplasma Pneumonia Live Vaccine Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Swine Mycoplasma Pneumonia Live Vaccine Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Swine Mycoplasma Pneumonia Live Vaccine Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Swine Mycoplasma Pneumonia Live Vaccine Production Market Share (2018-2023)
Table 47. World Swine Mycoplasma Pneumonia Live Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Swine Mycoplasma Pneumonia Live Vaccine Production by Type (2018-2023) & (K Units)
Table 49. World Swine Mycoplasma Pneumonia Live Vaccine Production by Type (2024-2029) & (K Units)
Table 50. World Swine Mycoplasma Pneumonia Live Vaccine Production Value by Type (2018-2023) & (USD Million)
Table 51. World Swine Mycoplasma Pneumonia Live Vaccine Production Value by Type (2024-2029) & (USD Million)
Table 52. World Swine Mycoplasma Pneumonia Live Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Swine Mycoplasma Pneumonia Live Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Swine Mycoplasma Pneumonia Live Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Swine Mycoplasma Pneumonia Live Vaccine Production by Application (2018-2023) & (K Units)
Table 56. World Swine Mycoplasma Pneumonia Live Vaccine Production by Application (2024-2029) & (K Units)
Table 57. World Swine Mycoplasma Pneumonia Live Vaccine Production Value by Application (2018-2023) & (USD Million)
Table 58. World Swine Mycoplasma Pneumonia Live Vaccine Production Value by Application (2024-2029) & (USD Million)
Table 59. World Swine Mycoplasma Pneumonia Live Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Swine Mycoplasma Pneumonia Live Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Zoetis Basic Information, Manufacturing Base and Competitors
Table 62. Zoetis Major Business
Table 63. Zoetis Swine Mycoplasma Pneumonia Live Vaccine Product and Services
Table 64. Zoetis Swine Mycoplasma Pneumonia Live Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Zoetis Recent Developments/Updates
Table 66. Zoetis Competitive Strengths & Weaknesses
Table 67. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 68. Boehringer Ingelheim Major Business
Table 69. Boehringer Ingelheim Swine Mycoplasma Pneumonia Live Vaccine Product and Services
Table 70. Boehringer Ingelheim Swine Mycoplasma Pneumonia Live Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Boehringer Ingelheim Recent Developments/Updates
Table 72. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 73. Merck Basic Information, Manufacturing Base and Competitors
Table 74. Merck Major Business
Table 75. Merck Swine Mycoplasma Pneumonia Live Vaccine Product and Services
Table 76. Merck Swine Mycoplasma Pneumonia Live Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Merck Recent Developments/Updates
Table 78. Merck Competitive Strengths & Weaknesses
Table 79. HIPRA Basic Information, Manufacturing Base and Competitors
Table 80. HIPRA Major Business
Table 81. HIPRA Swine Mycoplasma Pneumonia Live Vaccine Product and Services
Table 82. HIPRA Swine Mycoplasma Pneumonia Live Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. HIPRA Recent Developments/Updates
Table 84. HIPRA Competitive Strengths & Weaknesses
Table 85. Ceva Sant? Animale Basic Information, Manufacturing Base and Competitors
Table 86. Ceva Sant? Animale Major Business
Table 87. Ceva Sant? Animale Swine Mycoplasma Pneumonia Live Vaccine Product and Services
Table 88. Ceva Sant? Animale Swine Mycoplasma Pneumonia Live Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Ceva Sant? Animale Recent Developments/Updates
Table 90. Ceva Sant? Animale Competitive Strengths & Weaknesses
Table 91. Harbin Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 92. Harbin Pharmaceutical Group Major Business
Table 93. Harbin Pharmaceutical Group Swine Mycoplasma Pneumonia Live Vaccine Product and Services
Table 94. Harbin Pharmaceutical Group Swine Mycoplasma Pneumonia Live Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Harbin Pharmaceutical Group Recent Developments/Updates
Table 96. Harbin Pharmaceutical Group Competitive Strengths & Weaknesses
Table 97. Qilu Animal Health Products Basic Information, Manufacturing Base and Competitors
Table 98. Qilu Animal Health Products Major Business
Table 99. Qilu Animal Health Products Swine Mycoplasma Pneumonia Live Vaccine Product and Services
Table 100. Qilu Animal Health Products Swine Mycoplasma Pneumonia Live Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Qilu Animal Health Products Recent Developments/Updates
Table 102. Qilu Animal Health Products Competitive Strengths & Weaknesses
Table 103. Guangdong Winsun Bio-Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 104. Guangdong Winsun Bio-Pharmaceutical Major Business
Table 105. Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Pneumonia Live Vaccine Product and Services
Table 106. Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Pneumonia Live Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Guangdong Winsun Bio-Pharmaceutical Recent Developments/Updates
Table 108. Guangdong Winsun Bio-Pharmaceutical Competitive Strengths & Weaknesses
Table 109. Jilin HeYuan Bioengineering Basic Information, Manufacturing Base and Competitors
Table 110. Jilin HeYuan Bioengineering Major Business
Table 111. Jilin HeYuan Bioengineering Swine Mycoplasma Pneumonia Live Vaccine Product and Services
Table 112. Jilin HeYuan Bioengineering Swine Mycoplasma Pneumonia Live Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Jilin HeYuan Bioengineering Recent Developments/Updates
Table 114. Jofunhwa Biotechnology Basic Information, Manufacturing Base and Competitors
Table 115. Jofunhwa Biotechnology Major Business
Table 116. Jofunhwa Biotechnology Swine Mycoplasma Pneumonia Live Vaccine Product and Services
Table 117. Jofunhwa Biotechnology Swine Mycoplasma Pneumonia Live Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 118. Global Key Players of Swine Mycoplasma Pneumonia Live Vaccine Upstream (Raw Materials)
Table 119. Swine Mycoplasma Pneumonia Live Vaccine Typical Customers
Table 120. Swine Mycoplasma Pneumonia Live Vaccine Typical Distributors
Table 1. World Swine Mycoplasma Pneumonia Live Vaccine Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Swine Mycoplasma Pneumonia Live Vaccine Production Value by Region (2018-2023) & (USD Million)
Table 3. World Swine Mycoplasma Pneumonia Live Vaccine Production Value by Region (2024-2029) & (USD Million)
Table 4. World Swine Mycoplasma Pneumonia Live Vaccine Production Value Market Share by Region (2018-2023)
Table 5. World Swine Mycoplasma Pneumonia Live Vaccine Production Value Market Share by Region (2024-2029)
Table 6. World Swine Mycoplasma Pneumonia Live Vaccine Production by Region (2018-2023) & (K Units)
Table 7. World Swine Mycoplasma Pneumonia Live Vaccine Production by Region (2024-2029) & (K Units)
Table 8. World Swine Mycoplasma Pneumonia Live Vaccine Production Market Share by Region (2018-2023)
Table 9. World Swine Mycoplasma Pneumonia Live Vaccine Production Market Share by Region (2024-2029)
Table 10. World Swine Mycoplasma Pneumonia Live Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Swine Mycoplasma Pneumonia Live Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Swine Mycoplasma Pneumonia Live Vaccine Major Market Trends
Table 13. World Swine Mycoplasma Pneumonia Live Vaccine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Swine Mycoplasma Pneumonia Live Vaccine Consumption by Region (2018-2023) & (K Units)
Table 15. World Swine Mycoplasma Pneumonia Live Vaccine Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Swine Mycoplasma Pneumonia Live Vaccine Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Swine Mycoplasma Pneumonia Live Vaccine Producers in 2022
Table 18. World Swine Mycoplasma Pneumonia Live Vaccine Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Swine Mycoplasma Pneumonia Live Vaccine Producers in 2022
Table 20. World Swine Mycoplasma Pneumonia Live Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Swine Mycoplasma Pneumonia Live Vaccine Company Evaluation Quadrant
Table 22. World Swine Mycoplasma Pneumonia Live Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Swine Mycoplasma Pneumonia Live Vaccine Production Site of Key Manufacturer
Table 24. Swine Mycoplasma Pneumonia Live Vaccine Market: Company Product Type Footprint
Table 25. Swine Mycoplasma Pneumonia Live Vaccine Market: Company Product Application Footprint
Table 26. Swine Mycoplasma Pneumonia Live Vaccine Competitive Factors
Table 27. Swine Mycoplasma Pneumonia Live Vaccine New Entrant and Capacity Expansion Plans
Table 28. Swine Mycoplasma Pneumonia Live Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Swine Mycoplasma Pneumonia Live Vaccine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Swine Mycoplasma Pneumonia Live Vaccine Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Swine Mycoplasma Pneumonia Live Vaccine Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Swine Mycoplasma Pneumonia Live Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Swine Mycoplasma Pneumonia Live Vaccine Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Swine Mycoplasma Pneumonia Live Vaccine Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Swine Mycoplasma Pneumonia Live Vaccine Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Swine Mycoplasma Pneumonia Live Vaccine Production Market Share (2018-2023)
Table 37. China Based Swine Mycoplasma Pneumonia Live Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Swine Mycoplasma Pneumonia Live Vaccine Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Swine Mycoplasma Pneumonia Live Vaccine Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Swine Mycoplasma Pneumonia Live Vaccine Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Swine Mycoplasma Pneumonia Live Vaccine Production Market Share (2018-2023)
Table 42. Rest of World Based Swine Mycoplasma Pneumonia Live Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Swine Mycoplasma Pneumonia Live Vaccine Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Swine Mycoplasma Pneumonia Live Vaccine Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Swine Mycoplasma Pneumonia Live Vaccine Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Swine Mycoplasma Pneumonia Live Vaccine Production Market Share (2018-2023)
Table 47. World Swine Mycoplasma Pneumonia Live Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Swine Mycoplasma Pneumonia Live Vaccine Production by Type (2018-2023) & (K Units)
Table 49. World Swine Mycoplasma Pneumonia Live Vaccine Production by Type (2024-2029) & (K Units)
Table 50. World Swine Mycoplasma Pneumonia Live Vaccine Production Value by Type (2018-2023) & (USD Million)
Table 51. World Swine Mycoplasma Pneumonia Live Vaccine Production Value by Type (2024-2029) & (USD Million)
Table 52. World Swine Mycoplasma Pneumonia Live Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Swine Mycoplasma Pneumonia Live Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Swine Mycoplasma Pneumonia Live Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Swine Mycoplasma Pneumonia Live Vaccine Production by Application (2018-2023) & (K Units)
Table 56. World Swine Mycoplasma Pneumonia Live Vaccine Production by Application (2024-2029) & (K Units)
Table 57. World Swine Mycoplasma Pneumonia Live Vaccine Production Value by Application (2018-2023) & (USD Million)
Table 58. World Swine Mycoplasma Pneumonia Live Vaccine Production Value by Application (2024-2029) & (USD Million)
Table 59. World Swine Mycoplasma Pneumonia Live Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Swine Mycoplasma Pneumonia Live Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Zoetis Basic Information, Manufacturing Base and Competitors
Table 62. Zoetis Major Business
Table 63. Zoetis Swine Mycoplasma Pneumonia Live Vaccine Product and Services
Table 64. Zoetis Swine Mycoplasma Pneumonia Live Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Zoetis Recent Developments/Updates
Table 66. Zoetis Competitive Strengths & Weaknesses
Table 67. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 68. Boehringer Ingelheim Major Business
Table 69. Boehringer Ingelheim Swine Mycoplasma Pneumonia Live Vaccine Product and Services
Table 70. Boehringer Ingelheim Swine Mycoplasma Pneumonia Live Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Boehringer Ingelheim Recent Developments/Updates
Table 72. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 73. Merck Basic Information, Manufacturing Base and Competitors
Table 74. Merck Major Business
Table 75. Merck Swine Mycoplasma Pneumonia Live Vaccine Product and Services
Table 76. Merck Swine Mycoplasma Pneumonia Live Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Merck Recent Developments/Updates
Table 78. Merck Competitive Strengths & Weaknesses
Table 79. HIPRA Basic Information, Manufacturing Base and Competitors
Table 80. HIPRA Major Business
Table 81. HIPRA Swine Mycoplasma Pneumonia Live Vaccine Product and Services
Table 82. HIPRA Swine Mycoplasma Pneumonia Live Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. HIPRA Recent Developments/Updates
Table 84. HIPRA Competitive Strengths & Weaknesses
Table 85. Ceva Sant? Animale Basic Information, Manufacturing Base and Competitors
Table 86. Ceva Sant? Animale Major Business
Table 87. Ceva Sant? Animale Swine Mycoplasma Pneumonia Live Vaccine Product and Services
Table 88. Ceva Sant? Animale Swine Mycoplasma Pneumonia Live Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Ceva Sant? Animale Recent Developments/Updates
Table 90. Ceva Sant? Animale Competitive Strengths & Weaknesses
Table 91. Harbin Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 92. Harbin Pharmaceutical Group Major Business
Table 93. Harbin Pharmaceutical Group Swine Mycoplasma Pneumonia Live Vaccine Product and Services
Table 94. Harbin Pharmaceutical Group Swine Mycoplasma Pneumonia Live Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Harbin Pharmaceutical Group Recent Developments/Updates
Table 96. Harbin Pharmaceutical Group Competitive Strengths & Weaknesses
Table 97. Qilu Animal Health Products Basic Information, Manufacturing Base and Competitors
Table 98. Qilu Animal Health Products Major Business
Table 99. Qilu Animal Health Products Swine Mycoplasma Pneumonia Live Vaccine Product and Services
Table 100. Qilu Animal Health Products Swine Mycoplasma Pneumonia Live Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Qilu Animal Health Products Recent Developments/Updates
Table 102. Qilu Animal Health Products Competitive Strengths & Weaknesses
Table 103. Guangdong Winsun Bio-Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 104. Guangdong Winsun Bio-Pharmaceutical Major Business
Table 105. Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Pneumonia Live Vaccine Product and Services
Table 106. Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Pneumonia Live Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Guangdong Winsun Bio-Pharmaceutical Recent Developments/Updates
Table 108. Guangdong Winsun Bio-Pharmaceutical Competitive Strengths & Weaknesses
Table 109. Jilin HeYuan Bioengineering Basic Information, Manufacturing Base and Competitors
Table 110. Jilin HeYuan Bioengineering Major Business
Table 111. Jilin HeYuan Bioengineering Swine Mycoplasma Pneumonia Live Vaccine Product and Services
Table 112. Jilin HeYuan Bioengineering Swine Mycoplasma Pneumonia Live Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Jilin HeYuan Bioengineering Recent Developments/Updates
Table 114. Jofunhwa Biotechnology Basic Information, Manufacturing Base and Competitors
Table 115. Jofunhwa Biotechnology Major Business
Table 116. Jofunhwa Biotechnology Swine Mycoplasma Pneumonia Live Vaccine Product and Services
Table 117. Jofunhwa Biotechnology Swine Mycoplasma Pneumonia Live Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 118. Global Key Players of Swine Mycoplasma Pneumonia Live Vaccine Upstream (Raw Materials)
Table 119. Swine Mycoplasma Pneumonia Live Vaccine Typical Customers
Table 120. Swine Mycoplasma Pneumonia Live Vaccine Typical Distributors
LIST OF FIGURES
Figure 1. Swine Mycoplasma Pneumonia Live Vaccine Picture
Figure 2. World Swine Mycoplasma Pneumonia Live Vaccine Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Swine Mycoplasma Pneumonia Live Vaccine Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Swine Mycoplasma Pneumonia Live Vaccine Production (2018-2029) & (K Units)
Figure 5. World Swine Mycoplasma Pneumonia Live Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 6. World Swine Mycoplasma Pneumonia Live Vaccine Production Value Market Share by Region (2018-2029)
Figure 7. World Swine Mycoplasma Pneumonia Live Vaccine Production Market Share by Region (2018-2029)
Figure 8. North America Swine Mycoplasma Pneumonia Live Vaccine Production (2018-2029) & (K Units)
Figure 9. Europe Swine Mycoplasma Pneumonia Live Vaccine Production (2018-2029) & (K Units)
Figure 10. China Swine Mycoplasma Pneumonia Live Vaccine Production (2018-2029) & (K Units)
Figure 11. Japan Swine Mycoplasma Pneumonia Live Vaccine Production (2018-2029) & (K Units)
Figure 12. Swine Mycoplasma Pneumonia Live Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Swine Mycoplasma Pneumonia Live Vaccine Consumption (2018-2029) & (K Units)
Figure 15. World Swine Mycoplasma Pneumonia Live Vaccine Consumption Market Share by Region (2018-2029)
Figure 16. United States Swine Mycoplasma Pneumonia Live Vaccine Consumption (2018-2029) & (K Units)
Figure 17. China Swine Mycoplasma Pneumonia Live Vaccine Consumption (2018-2029) & (K Units)
Figure 18. Europe Swine Mycoplasma Pneumonia Live Vaccine Consumption (2018-2029) & (K Units)
Figure 19. Japan Swine Mycoplasma Pneumonia Live Vaccine Consumption (2018-2029) & (K Units)
Figure 20. South Korea Swine Mycoplasma Pneumonia Live Vaccine Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Swine Mycoplasma Pneumonia Live Vaccine Consumption (2018-2029) & (K Units)
Figure 22. India Swine Mycoplasma Pneumonia Live Vaccine Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Swine Mycoplasma Pneumonia Live Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Swine Mycoplasma Pneumonia Live Vaccine Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Swine Mycoplasma Pneumonia Live Vaccine Markets in 2022
Figure 26. United States VS China: Swine Mycoplasma Pneumonia Live Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Swine Mycoplasma Pneumonia Live Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Swine Mycoplasma Pneumonia Live Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Swine Mycoplasma Pneumonia Live Vaccine Production Market Share 2022
Figure 30. China Based Manufacturers Swine Mycoplasma Pneumonia Live Vaccine Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Swine Mycoplasma Pneumonia Live Vaccine Production Market Share 2022
Figure 32. World Swine Mycoplasma Pneumonia Live Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Swine Mycoplasma Pneumonia Live Vaccine Production Value Market Share by Type in 2022
Figure 34. 168 Strains
Figure 35. RM48 Strains
Figure 36. Other
Figure 37. World Swine Mycoplasma Pneumonia Live Vaccine Production Market Share by Type (2018-2029)
Figure 38. World Swine Mycoplasma Pneumonia Live Vaccine Production Value Market Share by Type (2018-2029)
Figure 39. World Swine Mycoplasma Pneumonia Live Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World Swine Mycoplasma Pneumonia Live Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Swine Mycoplasma Pneumonia Live Vaccine Production Value Market Share by Application in 2022
Figure 42. Piglets
Figure 43. Adult Pigs
Figure 44. World Swine Mycoplasma Pneumonia Live Vaccine Production Market Share by Application (2018-2029)
Figure 45. World Swine Mycoplasma Pneumonia Live Vaccine Production Value Market Share by Application (2018-2029)
Figure 46. World Swine Mycoplasma Pneumonia Live Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. Swine Mycoplasma Pneumonia Live Vaccine Industry Chain
Figure 48. Swine Mycoplasma Pneumonia Live Vaccine Procurement Model
Figure 49. Swine Mycoplasma Pneumonia Live Vaccine Sales Model
Figure 50. Swine Mycoplasma Pneumonia Live Vaccine Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
Figure 1. Swine Mycoplasma Pneumonia Live Vaccine Picture
Figure 2. World Swine Mycoplasma Pneumonia Live Vaccine Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Swine Mycoplasma Pneumonia Live Vaccine Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Swine Mycoplasma Pneumonia Live Vaccine Production (2018-2029) & (K Units)
Figure 5. World Swine Mycoplasma Pneumonia Live Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 6. World Swine Mycoplasma Pneumonia Live Vaccine Production Value Market Share by Region (2018-2029)
Figure 7. World Swine Mycoplasma Pneumonia Live Vaccine Production Market Share by Region (2018-2029)
Figure 8. North America Swine Mycoplasma Pneumonia Live Vaccine Production (2018-2029) & (K Units)
Figure 9. Europe Swine Mycoplasma Pneumonia Live Vaccine Production (2018-2029) & (K Units)
Figure 10. China Swine Mycoplasma Pneumonia Live Vaccine Production (2018-2029) & (K Units)
Figure 11. Japan Swine Mycoplasma Pneumonia Live Vaccine Production (2018-2029) & (K Units)
Figure 12. Swine Mycoplasma Pneumonia Live Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Swine Mycoplasma Pneumonia Live Vaccine Consumption (2018-2029) & (K Units)
Figure 15. World Swine Mycoplasma Pneumonia Live Vaccine Consumption Market Share by Region (2018-2029)
Figure 16. United States Swine Mycoplasma Pneumonia Live Vaccine Consumption (2018-2029) & (K Units)
Figure 17. China Swine Mycoplasma Pneumonia Live Vaccine Consumption (2018-2029) & (K Units)
Figure 18. Europe Swine Mycoplasma Pneumonia Live Vaccine Consumption (2018-2029) & (K Units)
Figure 19. Japan Swine Mycoplasma Pneumonia Live Vaccine Consumption (2018-2029) & (K Units)
Figure 20. South Korea Swine Mycoplasma Pneumonia Live Vaccine Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Swine Mycoplasma Pneumonia Live Vaccine Consumption (2018-2029) & (K Units)
Figure 22. India Swine Mycoplasma Pneumonia Live Vaccine Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Swine Mycoplasma Pneumonia Live Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Swine Mycoplasma Pneumonia Live Vaccine Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Swine Mycoplasma Pneumonia Live Vaccine Markets in 2022
Figure 26. United States VS China: Swine Mycoplasma Pneumonia Live Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Swine Mycoplasma Pneumonia Live Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Swine Mycoplasma Pneumonia Live Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Swine Mycoplasma Pneumonia Live Vaccine Production Market Share 2022
Figure 30. China Based Manufacturers Swine Mycoplasma Pneumonia Live Vaccine Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Swine Mycoplasma Pneumonia Live Vaccine Production Market Share 2022
Figure 32. World Swine Mycoplasma Pneumonia Live Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Swine Mycoplasma Pneumonia Live Vaccine Production Value Market Share by Type in 2022
Figure 34. 168 Strains
Figure 35. RM48 Strains
Figure 36. Other
Figure 37. World Swine Mycoplasma Pneumonia Live Vaccine Production Market Share by Type (2018-2029)
Figure 38. World Swine Mycoplasma Pneumonia Live Vaccine Production Value Market Share by Type (2018-2029)
Figure 39. World Swine Mycoplasma Pneumonia Live Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World Swine Mycoplasma Pneumonia Live Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Swine Mycoplasma Pneumonia Live Vaccine Production Value Market Share by Application in 2022
Figure 42. Piglets
Figure 43. Adult Pigs
Figure 44. World Swine Mycoplasma Pneumonia Live Vaccine Production Market Share by Application (2018-2029)
Figure 45. World Swine Mycoplasma Pneumonia Live Vaccine Production Value Market Share by Application (2018-2029)
Figure 46. World Swine Mycoplasma Pneumonia Live Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. Swine Mycoplasma Pneumonia Live Vaccine Industry Chain
Figure 48. Swine Mycoplasma Pneumonia Live Vaccine Procurement Model
Figure 49. Swine Mycoplasma Pneumonia Live Vaccine Sales Model
Figure 50. Swine Mycoplasma Pneumonia Live Vaccine Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
